Currently out of the existing stock ratings of David Low, 15 are a HOLD (40.54%), 19 are a BUY (51.35%), 3 are a SELL (8.11%).
Analyst David Low, currently employed at JPMORGAN, has had 72.73% of price targets met with an average potential upside of 33.2%, reached in 239 days on average. Previously, David Low worked at OPPENHEIMER, MORGAN STANLEY.
David Low has documented 65 price targets and ratings displayed on 4 stocks. The coverage is on Healthcare, Consumer Cyclical, Industrials sectors.
Most recent stock forecast was given on RMD, ResMed at 15-Apr-2026.
Analyst best performing recommendations are on NN (NEXTNAV ACQUISITION CORP).
The best stock recommendation documented was for RMD (RESMED) on 5/21/2021. The price target of $219 was fulfilled within 24 days with a profit of $26.12 (13.54%), with a performance score of 5.64.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 13-Oct-2025
$250
$10.47 (4.37%)
$215
17 days ago
(30-Oct-2026)
4/6 (66.67%)
$20.06 (8.72%)
40
Buy Since 06-Feb-2024
$277
$37.47 (15.64%)
$267
17 days ago
(30-Oct-2026)
7/16 (43.75%)
$47.06 (20.47%)
144
Buy Since 30-Oct-2026
$288
$48.47 (20.24%)
$262
17 days ago
(30-Oct-2026)
27/35 (77.14%)
$58.06 (25.25%)
279
Hold Since 30-Oct-2026
$270
$30.47 (12.72%)
$235
17 days ago
(30-Oct-2026)
9/15 (60%)
$40.06 (17.42%)
60
Hold Since 19-Aug-2026
$230
$8 (3.60%)
2 months 28 days ago
(19-Aug-2026)
1/1 (100%)
$0.01 (0.00%)
2
What Year was the first public recommendation made by David Low?